KANE & ROSS CLINICS LIMITEDActive

Company number 04837185Private limited companyIncorporated 2003

Key figures

£556,922-23.2%
Net assets 2024/25
-5.5%
Average annual change 2019/20–2024/25
0200 k400 k600 k800 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, KANE & ROSS CLINICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand90,08862,74699,05734,17574,523
Total assets979,491973,9491,020,0571,152,620949,296
Total liabilities171,060222,513291,219338,314350,117
Net assets / total equity787,107721,148693,780725,439556,922
Average number of employees44440

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: KANE & ROSS CLINICS LIMITED

Company

KANE & ROSS CLINICS LIMITED is a private limited company registered with Companies House under company number 04837185. It was incorporated on 18 Jul 2003. Its status is active. The registered office is in London (W1G). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files small company accounts (filleted). Net assets were £556,922, down 23.2% on the previous year. Cash at bank and in hand was £74,523. Total assets were £949,296 and total liabilities £350,117. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 10 Jun 2027.